Another Phase Ib/II trial exploring the safety and efficacy of capmatinib treatment with cetuximab, an anti-EGFR antibody, in HNSCC and metastatic colorectal cancers positive for c-MET has recently been suspended for unknown reasons (NCT02205398)
Final purified proteins were stored in 20 mM Tris-HCl pH 8.0, 150 mM NaCl buffer, unless specified otherwise, and stored at 80 C until further use
Baseline assessment should include metabolic panel, liver and kidney function, lipid profile, and assessment for GI disorders
Evidence suggests that weight losswhether through lifestyle changes or GLP-1 medicationsmay reduce the severity and frequency of HS flares for some patients
Athletes and fitness enthusiasts often notice reduced recovery times between training sessions
The last decade has been characterized by a dramatic increase in the number of children diagnosed with ASD